Condition
Vaccinations
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06820710Not ApplicableCompleted
Multidomain Interventions for Elderly Individuals in Residential Structures
NCT05302908Not ApplicableCompleted
COVID-19 Testing and Vaccination Among Spanish Speakers
NCT05329506CompletedPrimary
Attitudes and Believes About Vaccinations in a Supportive Care Patient Population
NCT03975517Completed
Sexual Risks in Prep Users
NCT03428776Not ApplicableCompletedPrimary
Timeliness of Immunization and Compliance Assessment Study
Showing all 5 trials